Gregory Divis | executive |
Richard Kim | executive |
Thomas McHugh | executive |
François Brisebois | analyst |
Ami Fadia | analyst |
David Amsellem | analyst |
Marc Goodman | analyst |
Ashwani Verma | analyst |
Oren Livnat | analyst |
Jason Gerberry | analyst |
Myriam Belghiti | analyst |
Matthew Kaplan | analyst |
Greetings, and welcome to Avadel Pharmaceuticals First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Austin Marta with Stern Investor Relations. Thank you.
You may begin.